IL6 - Interleukin 6

Introduction

Il6 Interleukin 6 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

}

Overview

The IL6 gene encodes Interleukin-6 (IL-6), a pleiotropic pro-inflammatory cytokine with critical roles in immune regulation, inflammation, hematopoiesis, and acute phase responses^{2IL-6 family of cytokines in the central nervous system2014 · PMID 25207119Open reference}1. IL-6 is produced by various cell types including immune cells (macrophages, dendritic cells, B cells), glial cells (astrocytes, microglia), and neurons^{2IL-6 family of cytokines in the central nervous system2014 · PMID 25207119Open reference}2. In the nervous system, IL-6 has both beneficial (neuroprotective, regenerative) and detrimental (chronic neuroinflammation, excitotoxicity) effects depending on context and timing^{2IL-6 family of cytokines in the central nervous system2014 · PMID 25207119Open reference}3. Dysregulated IL-6 signaling is implicated in the pathogenesis of Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and other neurodegenerative disorders^{2IL-6 family of cytokines in the central nervous system2014 · PMID 25207119Open reference}4.

Molecular Function

Receptor Signaling

IL-6 signals through two distinct pathways:

Classical Signaling

• IL-6R (CD126): Membrane-bound receptor

• gp130 (CD130): Signal-transducing subunit (shared with other IL-6 family cytokines)

• JAK/STAT3: Primary signaling pathway

• MAPK/ERK: Secondary signaling cascade

Trans-Signaling

• Soluble IL-6R (sIL-6R): Generated by proteolytic cleavage or alternative splicing

• Trans-signaling: Enables IL-6 response in cells lacking membrane IL-6R

• Pro-inflammatory: Trans-signaling is primarily pro-inflammatory

Signaling Pathways

Pathway	Key Molecules	Biological Outcome
JAK/STAT3	JAK1/2, STAT3, SOCS3	Gene transcription, acute phase response
MAPK/ERK	Ras, Raf, MEK, ERK1/2	Cell proliferation, differentiation
PI3K/Akt	PI3K, PDK, Akt	Cell survival, metabolism
NF-κB	IKK, IκB, p65/p50	Pro-inflammatory gene expression

Biological Activities

Activity	Mechanism	CNS Relevance
Acute Phase Response	Hepcidin, CRP induction	Systemic inflammation
B Cell Differentiation	Plasma cell formation	Autoantibody production
Hematopoiesis	Stem cell proliferation	Immune cell development
Neuronal Survival	STAT3 activation	Neuroprotection
Thermoregulation	Hypothalamic effects	Fever generation

Expression Pattern

Peripheral Immune System

• Macrophages/Monocytes: Primary source, TLR-stimulated

• Dendritic Cells: Professional antigen-presenting cells

• B Cells: Activated plasma cells

• T Cells: Th17 differentiation

Central Nervous System

Cell Type	Expression Level	Conditions
Astrocytes	Moderate	Injury, inflammation
Microglia	High	Chronic activation
Neurons	Low	Activity-dependent
Oligodendrocytes	Low	Demyelination
Endothelial Cells	Moderate	BBB inflammation

Disease Associations

Alzheimer’s Disease

IL-6 is a key mediator of chronic neuroinflammation in Alzheimer’s disease^{2IL-6 family of cytokines in the central nervous system2014 · PMID 25207119Open reference}5:

• CSF IL-6: Elevated in AD patients, correlates with disease progression

• Amyloid Interaction: Aβ stimulates IL-6 production in microglia

• Tau Pathology: IL-6 promotes tau phosphorylation via STAT3

• Blood-Brain Barrier: IL-6 increases BBB permeability

• Therapeutic Target: IL-6R antagonists (tocilizumab, sarilumab) being investigated

Parkinson’s Disease

IL-6 contributes to dopaminergic neuron degeneration in PD^{2IL-6 family of cytokines in the central nervous system2014 · PMID 25207119Open reference}6:

• Substantia Nigra: Elevated IL-6 in PD brain tissue

• Microglial Activation: Chronic neuroinflammation

• Dopaminergic Toxicity: IL-6 enhances MPTP-induced damage

• Genetic Association: IL6 polymorphisms linked to PD risk

Multiple Sclerosis

IL-6 plays a complex role in MS pathogenesis^{2IL-6 family of cytokines in the central nervous system2014 · PMID 25207119Open reference}7:

• Th17 Differentiation: Critical for pathogenic Th17 cells

• Demyelination: IL-6 promotes oligodendrocyte death

• Blood-Brain Barrier: Increases endothelial permeability

• Therapeutic: IL-6R blockade is effective in some MS patients

Amyotrophic Lateral Sclerosis

• SOD1 Mice: Elevated IL-6 in spinal cord

• Disease Progression: Correlates with rapid progression

• Astrocyte Response: Reactive astrocytes produce IL-6

Stroke/Ischemia

• Ischemic Injury: IL-6 elevated post-stroke

• Dual Role: Neuroprotective (acute) vs. inflammatory (chronic)

• Therapeutic Window: Anti-IL-6 strategies being explored

Therapeutic Implications

Approved IL-6 Targeting Drugs

Drug	Target	Route	Indication
Tocilizumab	IL-6R	IV/SC	RA, Castleman’s disease, CRS
Sarilumab	IL-6R	SC	Rheumatoid arthritis
Siltuximab	IL-6	IV	Castleman’s disease
Clazakizumab	IL-6	SC	RA, PsA

Neurodegeneration Applications

Approach	Status	Challenges
IL-6R antibodies	Clinical trials	BBB penetration
JAK inhibitors	Preclinical	Broad immunosuppression
STAT3 inhibitors	Preclinical	CNS delivery
Gene therapy	Experimental	Targeting specificity

Animal Models

Transgenic/ knockout mice

• IL-6 transgenic: Neuronal expression causes neuroinflammation

• IL-6 knockout: Reduced neuroinflammation, altered behavior

• IL-6R conditional KO: Cell-type specific deletion studies

Disease Models

• 5xFAD mice: IL-6 elevation in brain

• MPTP model: IL-6 knockout mice protected

• EAE model: IL-6 critical for disease induction

Research Directions

Biomarker Development

• CSF IL-6: Diagnostic/prognostic marker

• Plasma IL-6: Peripheral inflammation marker

• Longitudinal Studies: Tracking disease progression

Therapeutic Strategies

• Blood-Brain Barrier Penetration: Engineering brain-penetrant IL-6 modulators

• Cell-Type Specificity: Targeting microglial IL-6 signaling

• Temporal Control: Acute vs. chronic IL-6 modulation

Key Publications

^{2IL-6 family of cytokines in the central nervous system2014 · PMID 25207119Open reference}8 Kishimoto T. IL-6: from its discovery to clinical applications. Int J Mol Sci. 2020;21(7):2280. ^{1IL-6: from its discovery to clinical applications2020 · PMID 32224333Open reference}(https://pubmed.ncbi.nlm.nih.gov/32224333/)
^{2IL-6 family of cytokines in the central nervous system2014 · PMID 25207119Open reference}9 Rothaug M, et al. IL-6 family of cytokines in the CNS. Adv Neurobiol. 2014;11:1-27. ^{2IL-6 family of cytokines in the central nervous system2014 · PMID 25207119Open reference}(https://pubmed.ncbi.nlm.nih.gov/25207119/)
^{3IL-6, a pleiotropic cytokine2012 · PMID 23055952Open reference}0 Erta M, et al. IL-6, a pleiotropic cytokine. Front Cell Neurosci. 2012;6:44. ^{3IL-6, a pleiotropic cytokine2012 · PMID 23055952Open reference}(https://pubmed.ncbi.nlm.nih.gov/23055952/)
^{3IL-6, a pleiotropic cytokine2012 · PMID 23055952Open reference}1 Quirié A, et al. Role of IL-6 in Alzheimer’s disease. J Neurol Sci. 2012;322(1-2):96-105. ^{4Role of IL-6 in Alzheimer's disease2012 · PMID 22710117Open reference}(https://pubmed.ncbi.nlm.nih.gov/22710117/)
^{3IL-6, a pleiotropic cytokine2012 · PMID 23055952Open reference}2 Ferrari CC, et al. IL-6 in Parkinson’s disease. Neurodegener Dis. 2006;3(4-5):285-290. ^{5Interleukin-6 in Parkinson's disease2006 · PMID 16954691Open reference}(https://pubmed.ncbi.nlm.nih.gov/16954691/)
^{3IL-6, a pleiotropic cytokine2012 · PMID 23055952Open reference}3 Lock C, et al. IL-6 in multiple sclerosis. J Immunol. 2002;169(6):3434-3441. ^{6Humanized mice are resistant to IL-6 in multiple sclerosis2002 · PMID 12218176Open reference}(https://pubmed.ncbi.nlm.nih.gov/12218176/)

Background

The study of Il6 Interleukin 6 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Allen Brain Atlas Data

Gene Expression

IL6 (Interleukin-6) expression patterns:

• Hippocampus - High expression in CA1 pyramidal neurons

• Cerebral cortex - Moderate expression in layer 5 neurons

• Hypothalamus - High expression

• Cerebellum - Moderate expression

Single-Cell Expression

IL6 is expressed in:

• Microglia (high levels - primary source in brain)

• Astrocytes (reactive astrocytes)

• Neurons (at lower levels)

• Endothelial cells

Brain Region Expression Levels

Region	Expression Level	Data Source
Hippocampus	High	Mouse Brain
Hypothalamus	High	Mouse Brain
Cortex	Medium	Mouse Brain
Cerebellum	Medium	Mouse Brain
Striatum	Low-Medium	Mouse Brain

See Also

• Proteins Index

• IL6 Protein

• Neuroinflammation Pathway

• Alzheimer’s Disease

• Parkinson’s Disease

• Multiple Sclerosis

• TNF Gene

• IL1B Gene

External Links

• NCBI Gene: IL6

• UniProt: IL6

• Ensembl: IL6

• OMIM: IL6